Kiniksa Pharmaceuticals International, plc (KNSA) vs Kodiak Sciences Inc. (KOD)

A side-by-side comparison of Kiniksa Pharmaceuticals International, plc and Kodiak Sciences Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — KNSA vs KOD

growth of $100 · dividends reinvested · last 8y
KNSA +220.5% (+15.7%/yr)KOD +4521.2% (+61.5%/yr)KOD compounded faster over this window
Log scale — wide-divergence pair
101001k10kStart $1002020202220242026$320$4,621
KNSA KOD

KNSA vs KOD: by the numbers

  • •KOD is the larger company ($5.89B vs $5.84B market cap).
  • •KNSA is profitable (9.59% net margin) while KOD runs a net loss (0.00%).

Metrics side by side

Valuation

MetricKNSAKOD
P/E ratio78.22N/A
Forward P/E55.04N/A
P/S ratio6.95N/A
P/B ratio8.9396.49
EV / EBITDA55.61N/A
FCF yield3.13%N/A

Profitability

MetricKNSAKOD
Gross margin54.49%0.00%
Operating margin11.92%0.00%
Net margin9.59%0.00%
ROE12.33%-396.09%
ROIC9.76%-115.23%

Growth (annualized)

MetricKNSAKOD
Revenue CAGR (5Y)155.66%N/A
Total return CAGR (5Y)47.48%36.19%

Frequently asked

Is KNSA or KOD more profitable?
KNSA runs the higher net margin — KNSA at 9.59% versus KOD at 0.00%.
How have KNSA and KOD total returns compared?
Over the past 5 years, KNSA delivered 47.48% and KOD delivered 36.19% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.